About us

The Berlin School of Integrative Oncology (BSIO) is funded within the Excellence Initiative of the German federal and state governments.

The BSIO offers a structured 3-year doctoral program jointly educating natural scientists and physicians/medical students in the field of integrative oncology and features excellent research conditions, a comprehensive curriculum and a broad supervision and mentoring network. Furthermore, students will have the opportunity to conduct part of their project in one of the labs of the renowed international partner institutions of the BSIO (depending on the individual project). The BSIO educational concept also includes the use of state-of-the-art technologies such as tablet computers for lab and office work, video conferencing and large-scale touch screen monitors.

With respect to its scientific scope, the BSIO aims to bring our understanding of malignant growth to new conceptual levels, i.e. to expand the molecular, cell biological, organismic and system-mathematical research focus by utilizing advanced experimental and simulatory models to develop novel diagnostics and innovative therapeutic principles, and to make them rapidly available for clinical testing.

Regarding its educational goals, the BSIO aims to sharpen scientific thinking and problem solving, and to provide an excellent research environment with inspiring international training structures in which highly talented graduate students and postgraduate scientists from all over the world will be guided through the early phases of their careers in translational and clinically-oriented cancer research. It is the central mission of the interdisciplinary graduate school to introduce basic scientists to the most demanding problems in clinical oncology, and, in turn, to stimulate young research-interested clinicians to translate unsolved clinical challenges into experimentally approachable questions, ultimately leading to their mechanistic explanation. It is the believe and the vision of the BSIO that only best trained scientists and clinicians capable of seamlessly communicating with each other will succeed together to overcome therapeutic barriers to the elimination of cancer by cooperatively developing innovative therapeutic solutions.